IGF1 and acute lymphoblastic leukemia: Indeed, inhibiting FAK/PYK2 significantly decreased myeloid-mediated activation of IGF1R in T-ALL cells (Fig. 5f, g) and diminished the enhanced survival of T-ALL to exogenous IGF1 in myeloid co-cultures (Fig. 5h).